| ²é¿´: 477 | »Ø¸´: 2 | ||
| ±¾Ìû²úÉú 1 ¸ö ·ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴 | ||
yin198716гæ (ÕýʽдÊÖ)
|
[ÇóÖú]
ÇóÕâ¾ä»°µÄ·Òë
|
|
| We also observed activation of other pathways of tumor resistance driven by DLL4-Notch signaling, including the FGF2-FGFR and EphB4-EprinB2 pathways, the inhibition of which reversed tumor resistance partially. |
» ²ÂÄãϲ»¶
¸´ÊÔµ÷¼Á
ÒѾÓÐ5È˻ظ´
Ò»Ö¾Ô¸±±¾©»¯¹¤085600 310·ÖÇóµ÷¼Á
ÒѾÓÐ11È˻ظ´
Ò»Ö¾Ô¸±±¾©2£¬²ÄÁÏÓ뻯¹¤308Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
0817»¯Ñ§¹¤³ÌÓë¼¼ÊõÇóµ÷¼Á£¬Ò»Ö¾Ô¸Öк£Ñó319
ÒѾÓÐ9È˻ظ´
Ò»Ö¾Ô¸µç×ӿƼ¼´óѧ085600²ÄÁÏÓ뻯¹¤ 329·ÖÇóµ÷¼Á
ÒѾÓÐ6È˻ظ´
304Çóµ÷¼Á£¨085602£¬¹ýËļ¶£¬Ò»Ö¾Ô¸985£©
ÒѾÓÐ7È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
Ò»Ö¾Ô¸±±¾©»¯¹¤´óѧ£¬³õÊԳɼ¨350Çóµ÷¼Á
ÒѾÓÐ14È˻ظ´
323·Ö£¨¼ÆËã»úÊÓ¾õºÍ´óÄ£ÐÍÏîÄ¿£©ÄÜÖ±½ÓÉÏÊÖ
ÒѾÓÐ3È˻ظ´
311·Ö 22408 Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´

Ƶ»Øíííù
ÖÁ×ðľ³æ (Ö°Òµ×÷¼Ò)
- ·ÒëEPI: 110
- Ó¦Öú: 13 (СѧÉú)
- ¹ó±ö: 0.566
- ½ð±Ò: 17171.4
- É¢½ð: 1586
- ºì»¨: 30
- ɳ·¢: 3
- Ìû×Ó: 3338
- ÔÚÏß: 545.1Сʱ
- ³æºÅ: 1238300
- ×¢²á: 2011-03-19
- ÐÔ±ð: GG
- רҵ: ½ðÊôÓлú»¯Ñ§

2Â¥2012-10-30 18:13:06
yunqi_2000
½ð³æ (СÓÐÃûÆø)
- ·ÒëEPI: 34
- Ó¦Öú: 2 (Ó×¶ùÔ°)
- ½ð±Ò: 1292
- ºì»¨: 3
- Ìû×Ó: 149
- ÔÚÏß: 60Сʱ
- ³æºÅ: 1920191
- ×¢²á: 2012-08-01
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï
°®ÓëÓêÏÂ: ½ð±Ò+1 2012-10-30 21:01:20
Carena: ½ð±Ò+3, ·ÒëEPI+1, ½ð±Ò´ú·¢ 2012-11-28 09:17:36
°®ÓëÓêÏÂ: ½ð±Ò+1 2012-10-30 21:01:20
Carena: ½ð±Ò+3, ·ÒëEPI+1, ½ð±Ò´ú·¢ 2012-11-28 09:17:36
|
ÎÒÃÇÒ²¹Û²âÁËÆäËüÓÉDLL4-NotchÐźÅÇý¶¯»ñÈ¡Ö×ÁöÄÍÒ©ÐÔµÄͨ·µÄ»îÐÔ£¬°üÀ¨FGF2-FGFR ºÍEphB4-EprinB2ͨ·£¬ËüÃǵÄÒÖÖÆ¿ÉÒÔ²¿·ÖµØ·´×ªÖ×ÁöÄÍÒ©ÐÔ¡£ ²éÁËÒ»ÏÂtumor resistance£º1. Ö×ÁöÄÍÒ©ÐÔ£¨Over time, it's possible for a tumor to develop resistance to treatment£» Tumor resistance to apoptosis.£©£»2. ¿¹Ö×Áö£¨Ò»ÖÖ×Ô·¢¿¹Ö×ÁöСÊóÄ£Ð͵Ľ¨Á¢¼°Æä¿¹Ö×Áö»úÖÆµÄÑо¿½øÕ¹ - Discovery of a tumor resistance mouse and investigation of its mechanism£©£»µ«ÊÇ£¬¿¹Ö×ÁöÒ»°ã¿ÉÄÜÓÃantitumor¡£ ËùÒÔÇãÏòÓÃÖ×ÁöÄÍÒ©ÐÔ£¬lz¸ù¾Ý¾ßÌåÓï¾³·Òë°É |

3Â¥2012-10-30 18:20:00














»Ø¸´´ËÂ¥